Powder X-ray diffraction of capecitabine, C15H22FN3O6 — CORRIGENDUM

James A. Kaduk; Amy M. Gindhart; Thomas N. Blanton

doi:10.1017/S0885715619000642

Powder X-ray diffraction of capecitabine, C15H22FN3O6 — CORRIGENDUM

Published online by Cambridge University Press: 12 September 2019

James A. Kaduk ,

Amy M. Gindhart and

Thomas N. Blanton

Article contents

Abstract
References

Rights & Permissions

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Type: Corrigendum
Information: Powder Diffraction , Volume 34 , Issue 3 , September 2019 , pp. 293

DOI: https://doi.org/10.1017/S0885715619000642 [Opens in a new window]
Copyright: Copyright © International Centre for Diffraction Data 2019

In Kaduk et al. (Reference Kaduk, Gindhart and Blanton2019), Figure 1 showed the incorrect chirality of the molecules.

The correct Figure 1 is shown below:

Figure 1. (Color online) Powder X-ray diffraction pattern of capecitabine. The Rietveld-refined structure is indicated in red, and the DFT-optimized structure is indicated in blue.

The original article has been corrected online to rectify this error.

References

Kaduk, J. A., Gindhart, A. M., and Blanton, T. N. (2019). “Powder X-ray diffraction of capecitabine, C₁₅H₂₂FN₃O₆,” Powder Diffr. doi:10.1017/S0885715619000575.Google Scholar

Figure 1. (Color online) Powder X-ray diffraction pattern of capecitabine. The Rietveld-refined structure is indicated in red, and the DFT-optimized structure is indicated in blue.